Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery

Journal of Acquired Immune Deficiency Syndromes

Volumn 64, Issue 1, 2013, Pages 58-65

  Aebi Popp, Karoline ^a,b   Mulcahy, Fiona ^b   Glass, Tracy R ^c,d   Rudin, Christoph ^e   Martinez De Tejada, Begona ^f   Bertisch, Barbara ^g   Fehr, Jan ^h   Grawe, Claudia ⁱ   Scheibner, Kathrin ^j   Rickenbach, Martin ^k   Hoesli, Irene ^a   Thorne, Claire ^l  

^a UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

^b ST JAMES S HOSPITAL   (Ireland)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^h UNIVERSITY HOSPITAL ZURICH   (Switzerland)

ⁱ UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

^j UNIVERSITY OF BERN   (Switzerland)

^k UNIVERSITY OF LAUSANNE   (Switzerland)

^l UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Europe; HIV; Mode of delivery; Pregnancy

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CESAREAN SECTION; EUROPE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; VAGINAL DELIVERY; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CESAREAN SECTION; COHORT STUDIES; DELIVERY, OBSTETRIC; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; GUIDELINES AS TOPIC; HEALTH POLICY; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SURGICAL PROCEDURES, ELECTIVE; VIRAL LOAD; VIRUS REPLICATION;

EID: 84883451777     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182a334e3     Document Type: Article

References (30)

1. Kind C, Rudin C, Siegrist CA, et al. Prevention of vertical HIV transmission: Additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group. AIDS. 1998;12:205-210
2. Elective Caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomised clinical trial. Lancet. 1999;353: 1035-1039
3. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - a meta-analysis of 15 prospective cohort studies. N Engl J Med. 1999; 340:977-987
4. Boer K, Nellen JF, Patel D, et al. The AmRo study: Pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery. BJOG. 2007;114:148-155
5. Warszawski J, Tubiana R, Le Chenadec J, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS. 2008;22:289-299
6. Townsend CL, Cortina-Borja M, Peckham CS, et al. Low rates of motherto-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS. 2008;22:973-981
7. Fiore S, Newell ML, Thorne C. Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery. AIDS. 2004;18:933-938
8. Read JS, Newell MK. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. Cochrane Database Syst Rev.2005:CD005479
9. Grubert TA, Reindell D, Kästner R, et al. Rates of postoperative complications among human immunodeficiency virus-infected women who have undergone obstetric and gynecologic surgical procedures. Clin Infect Dis. 2002;34:822-830
10. Rodriguez EJ, Spann C, Jamieson D, et al. Postoperative morbidity associated with cesarean delivery among human immunodeficiency virusseropositive women. Am J Obstet Gynecol. 2001;184:1108-1111
11. Teune MJ, Bakhuizen S, Gyamfi Bannerman C, et al. A systematic review of severe morbidity in infants born late preterm. Am J Obstet Gynecol. 2011;205:374.e1-374.e9
12. Viganò A, Pogliani L, Fasan S, et al. Morbidity rates in late preterms born to HIV-mothers. J Matern Fetal Neonatal Med. 2011;24:626-627
13. Aebi-Popp K, Mulcahy F, Rudin C, et al. National Guidelines for the prevention of mother-to-child transmission of HIV across Europe - how do countries differ? Eur J Public Health. [epub ahead of print]. PMID: 23478206
14. Tariq S, Townsend CL, Cortina-Borja M, et al. Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009. J Acquir Immune Defic Syndr. 2011;57:326-333
15. Boer K, England K, Godfried MH, et al. Mode of delivery in HIVinfected pregnant women and prevention of mother-to-child transmission: Changing practices in Western Europe. HIV Med. 2010;11: 368-378
16. Rudin C, Spaenhauer A, Keiser O, et al. Antiretroviral therapy during pregnancy and premature birth: Analysis of Swiss data. HIV Med. 2011; 12:228-235
17. Joao EC, Gouvêa MI, Menezes JA, et al. Factors associated with viral load suppression in HIV-infected pregnant women in Rio de Janeiro, Brazil. Int J STD AIDS. 2012;23:44-47
18. Katz IT, Shapiro R, Li D, et al. Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study. J Acquir Immune Defic Syndr. 2010;54:27-34
19. Mark S, Murphy KE, Read S, et al. HIV mother-to-child transmission, mode of delivery, and duration of rupture of membranes: Experience in the current era. Infect Dis Obstet Gynecol. 2012;2012:267969
20. Floridia M, Ravizza M, Pinnetti C, et al. Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy. HIV Clin Trials. 2010;11:303-311
21. European Collaborative Study, Patel D, Cortina-Borja M, Thorne C, et al. Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. Clin Infect Dis. 2007; 44:1647-1656
22. Habiba M, Kaminski M, Da Frè M, et al. Caesarean section on request: A comparison of obstetricians' attitudes in eight European countries. BJOG. 2006;113:647-656
23. Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med. 1999;341:385-393
24. Shapiro DE, Sperling RS, Mandelbrot L, et al. Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group. Obstet Gynecol. 1999;94:897-908
25. Duration of ruptured membranes and vertical transmission of HIV-1: A metaanalysis from 15 prospective cohort studies. AIDS. 2001;15:357-368
26. D'Souza R, Arulkumaran S. To "C" or not to "C"? Caesarean delivery upon maternal request: A review of facts, figures and guidelines. J Perinat Med. 2013;41:5-15
27. Suy A, Hernandez S, Thorne C, et al. Current guidelines on management of HIV-infected pregnant women: Impact on mode of delivery. Eur J Obstet Gynecol Reprod Biol. 2008;139:127-132
28. Livingston EG, Huo Y, Patel K, et al. Mode of delivery and infant respiratory morbidity among infants born to HIV-1-infected women. Obstet Gynecol. 2010;116(2 Pt 1):335-343
29. Azria E, Kane A, Tsatsaris V, et al. Term labor management and outcomes in treated HIV-infected women without contraindications to vaginal delivery and matched controls. Int J Gynaecol Obstet. 2010;111: 161-164
30. Cheng YW, Kaimal AJ, Bruckner TA, et al. Perinatal morbidity associated with late preterm deliveries compared with deliveries between 37 and 40 weeks of gestation. BJOG. 2011;118:1446-1454